Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 1 |
GO:0043226 | organelle | 2 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0005840 | ribosome | 5 | 1 |
Related structures:
AlphaFold database: E9AVA2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 209 | 215 | PF00089 | 0.399 |
CLV_NRD_NRD_1 | 172 | 174 | PF00675 | 0.495 |
CLV_PCSK_KEX2_1 | 112 | 114 | PF00082 | 0.489 |
CLV_PCSK_KEX2_1 | 120 | 122 | PF00082 | 0.444 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.446 |
CLV_PCSK_KEX2_1 | 96 | 98 | PF00082 | 0.460 |
CLV_PCSK_PC1ET2_1 | 112 | 114 | PF00082 | 0.496 |
CLV_PCSK_PC1ET2_1 | 120 | 122 | PF00082 | 0.433 |
CLV_PCSK_PC1ET2_1 | 5 | 7 | PF00082 | 0.446 |
CLV_PCSK_PC1ET2_1 | 96 | 98 | PF00082 | 0.460 |
CLV_PCSK_SKI1_1 | 11 | 15 | PF00082 | 0.464 |
CLV_PCSK_SKI1_1 | 120 | 124 | PF00082 | 0.479 |
CLV_PCSK_SKI1_1 | 174 | 178 | PF00082 | 0.411 |
DOC_ANK_TNKS_1 | 18 | 25 | PF00023 | 0.319 |
DOC_CKS1_1 | 175 | 180 | PF01111 | 0.557 |
DOC_MAPK_gen_1 | 254 | 263 | PF00069 | 0.544 |
DOC_MAPK_MEF2A_6 | 257 | 265 | PF00069 | 0.556 |
DOC_PP1_RVXF_1 | 255 | 261 | PF00149 | 0.537 |
DOC_PP2B_LxvP_1 | 81 | 84 | PF13499 | 0.368 |
DOC_PP4_FxxP_1 | 46 | 49 | PF00568 | 0.388 |
DOC_PP4_FxxP_1 | 65 | 68 | PF00568 | 0.432 |
DOC_USP7_MATH_1 | 163 | 167 | PF00917 | 0.662 |
DOC_WW_Pin1_4 | 151 | 156 | PF00397 | 0.469 |
DOC_WW_Pin1_4 | 174 | 179 | PF00397 | 0.450 |
LIG_14-3-3_CanoR_1 | 124 | 130 | PF00244 | 0.488 |
LIG_14-3-3_CanoR_1 | 77 | 84 | PF00244 | 0.400 |
LIG_FHA_1 | 145 | 151 | PF00498 | 0.573 |
LIG_FHA_1 | 195 | 201 | PF00498 | 0.425 |
LIG_FHA_1 | 253 | 259 | PF00498 | 0.433 |
LIG_FHA_1 | 76 | 82 | PF00498 | 0.392 |
LIG_FHA_1 | 8 | 14 | PF00498 | 0.429 |
LIG_FHA_2 | 175 | 181 | PF00498 | 0.495 |
LIG_Integrin_isoDGR_2 | 75 | 77 | PF01839 | 0.465 |
LIG_Integrin_RGD_1 | 113 | 115 | PF01839 | 0.498 |
LIG_KLC1_Yacidic_2 | 40 | 45 | PF13176 | 0.473 |
LIG_LIR_Apic_2 | 45 | 49 | PF02991 | 0.383 |
LIG_LIR_Apic_2 | 62 | 68 | PF02991 | 0.232 |
LIG_LIR_Gen_1 | 128 | 136 | PF02991 | 0.379 |
LIG_LIR_Gen_1 | 40 | 51 | PF02991 | 0.391 |
LIG_LIR_Nem_3 | 128 | 132 | PF02991 | 0.383 |
LIG_LIR_Nem_3 | 237 | 241 | PF02991 | 0.404 |
LIG_LIR_Nem_3 | 247 | 251 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 40 | 46 | PF02991 | 0.361 |
LIG_Pex14_2 | 238 | 242 | PF04695 | 0.398 |
LIG_Pex14_2 | 46 | 50 | PF04695 | 0.448 |
LIG_SH2_CRK | 101 | 105 | PF00017 | 0.413 |
LIG_SH2_STAP1 | 101 | 105 | PF00017 | 0.413 |
LIG_SH2_STAT3 | 15 | 18 | PF00017 | 0.561 |
LIG_SH2_STAT5 | 244 | 247 | PF00017 | 0.449 |
LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.463 |
LIG_SH3_3 | 166 | 172 | PF00018 | 0.546 |
LIG_TRAF2_1 | 37 | 40 | PF00917 | 0.540 |
MOD_CK1_1 | 153 | 159 | PF00069 | 0.581 |
MOD_CK1_1 | 193 | 199 | PF00069 | 0.495 |
MOD_CK1_1 | 249 | 255 | PF00069 | 0.398 |
MOD_CK1_1 | 29 | 35 | PF00069 | 0.680 |
MOD_GlcNHglycan | 156 | 159 | PF01048 | 0.661 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.645 |
MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.626 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.534 |
MOD_GSK3_1 | 190 | 197 | PF00069 | 0.437 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.679 |
MOD_N-GLC_1 | 252 | 257 | PF02516 | 0.537 |
MOD_NEK2_1 | 190 | 195 | PF00069 | 0.458 |
MOD_NEK2_1 | 230 | 235 | PF00069 | 0.435 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.441 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.415 |
MOD_PIKK_1 | 190 | 196 | PF00454 | 0.457 |
MOD_PKA_2 | 184 | 190 | PF00069 | 0.481 |
MOD_PKA_2 | 76 | 82 | PF00069 | 0.411 |
MOD_Plk_1 | 246 | 252 | PF00069 | 0.497 |
MOD_Plk_4 | 237 | 243 | PF00069 | 0.414 |
MOD_ProDKin_1 | 151 | 157 | PF00069 | 0.479 |
MOD_ProDKin_1 | 174 | 180 | PF00069 | 0.457 |
MOD_SUMO_for_1 | 234 | 237 | PF00179 | 0.454 |
TRG_DiLeu_BaEn_2 | 255 | 261 | PF01217 | 0.445 |
TRG_DiLeu_BaEn_4 | 39 | 45 | PF01217 | 0.442 |
TRG_DiLeu_BaLyEn_6 | 3 | 8 | PF01217 | 0.473 |
TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.414 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.437 |
TRG_ER_diArg_1 | 257 | 260 | PF00400 | 0.538 |
TRG_Pf-PMV_PEXEL_1 | 243 | 247 | PF00026 | 0.490 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HUF4 | Leptomonas seymouri | 77% | 100% |
A0A0S4JGP8 | Bodo saltans | 48% | 100% |
A0A1X0NYA3 | Trypanosomatidae | 54% | 89% |
A0A3Q8IC01 | Leishmania donovani | 93% | 100% |
A0A3R7N930 | Trypanosoma rangeli | 53% | 92% |
A4HBX4 | Leishmania braziliensis | 86% | 98% |
A4HZ94 | Leishmania infantum | 93% | 100% |
D0A178 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 90% |
Q4QC78 | Leishmania major | 94% | 100% |